Clinical Trials Browser

Phase 2 × Not yet recruiting × Immunotherapy, Adoptive × Clear all

NCT07612787 2026-05-29

BELAMI

Phase 2 Not yet recruiting

Multiple Myeloma, Neoplasms, Recurrence